As of 2026-02-07, the Relative Valuation of Microbix Biosystems Inc (MBX.TO) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.23 CAD, the upside of Microbix Biosystems Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2026-01-21 | -13.62 |
| 2026-01-20 | -13.62 |
| 2026-01-19 | -14.23 |
| 2026-01-16 | -14.85 |
| 2026-01-15 | -14.85 |
| 2026-01-14 | -14.85 |
| 2026-01-13 | -14.85 |
| 2026-01-12 | -14.85 |
| 2026-01-09 | -15.16 |
| 2026-01-08 | -14.54 |
| 2026-01-07 | -14.85 |
| 2026-01-06 | -15.16 |
| 2026-01-05 | -14.85 |
| 2026-01-02 | -14.85 |
| 2025-12-31 | -14.23 |
| 2025-12-30 | -14.54 |
| 2025-12-29 | -14.54 |
| 2025-12-24 | -14.23 |
| 2025-12-23 | -14.23 |
| 2025-12-22 | -14.23 |
| 2025-12-19 | -13.31 |
| 2025-12-18 | -13.00 |
| 2025-12-17 | -14.85 |
| 2025-12-16 | -14.85 |
| 2025-12-15 | -14.85 |
| 2025-12-12 | -15.16 |
| 2025-12-11 | -15.47 |
| 2025-12-10 | -14.54 |
| 2025-12-09 | -14.85 |
| 2025-12-08 | -15.16 |
| 2025-12-05 | -14.85 |
| 2025-12-04 | -14.85 |
| 2025-12-03 | -14.85 |
| 2025-12-02 | -14.85 |
| 2025-12-01 | -14.85 |
| 2025-11-28 | -15.16 |
| 2025-11-27 | -15.16 |
| 2025-11-26 | -14.85 |
| 2025-11-25 | -15.16 |
| 2025-11-24 | -14.85 |
| 2025-11-21 | -15.47 |
| 2025-11-20 | -14.54 |
| 2025-11-19 | -14.85 |
| 2025-11-18 | -14.85 |
| 2025-11-17 | -15.47 |
| 2025-11-14 | -15.16 |
| 2025-11-13 | -16.40 |
| 2025-11-12 | -16.09 |
| 2025-11-11 | -15.16 |
| 2025-11-10 | -15.16 |